Therapeutic Drug Monitoring Is Cost-Effective for Patients With Inflammatory Bowel Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Systematic Review on Cost-Effectiveness Analyses of Therapeutic Drug Monitoring for Patients With Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy
Inflamm. Bowel Dis. 2021 Jan 19;27(2)275-282, J Yao, X Jiang, JHS YouFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.